# ACASTI PHARMA INC (ACST)

> Institutional ownership reported to the SEC as of Q3 2024, from Form 13F filings. Source: https://holderbook.com/stocks/ACST/

- Reporting holders: 11
- Reported value: $3.5M
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [AIGH Capital Management LLC](https://holderbook.com/funds/1835943-aigh-capital-management-llc/) | $1.9M | 641,083 | 0.5% | 3 |
| [BANK OF AMERICA CORP /DE/](https://holderbook.com/funds/70858-bank-of-america-corp-de/) | $1.5M | 494,698 | 0.0% | 5 |
| [RENAISSANCE TECHNOLOGIES LLC](https://holderbook.com/funds/1037389-renaissance-technologies-llc/) | $48.4K | 16,147 | 0.0% | 1 |
| [Tower Research Capital LLC (TRC)](https://holderbook.com/funds/1533421-tower-research-capital-llc-trc/) | $8.2K | 2,732 | 0.0% | 1 |
| [NATIONAL BANK OF CANADA /FI/](https://holderbook.com/funds/926171-national-bank-of-canada-fi/) | $8.1K | 2,719 | 0.0% | 5 |
| [MORGAN STANLEY](https://holderbook.com/funds/895421-morgan-stanley/) | $5.6K | 1,882 | 0.0% | 5 |
| [Royal Bank of Canada](https://holderbook.com/funds/1000275-royal-bank-of-canada/) | $2.0K | 543 | 0.0% | 5 |
| [Activest Wealth Management](https://holderbook.com/funds/1883134-activest-wealth-management/) | $312 | 104 | 0.0% | 2 |
| [JPMORGAN CHASE & CO](https://holderbook.com/funds/19617-jpmorgan-chase-co/) | $102 | 34 | 0.0% | 2 |
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $84 | 28 | 0.0% | 5 |
| [Federation des caisses Desjardins du Quebec](https://holderbook.com/funds/2022297-federation-des-caisses-desjardins-du-quebec/) | $84 | 28 | 0.0% | 5 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2024 | 11 | $3.5M |
| Q2 2024 | 12 | $6.3M |
| Q1 2024 | 9 | $4.3M |
| Q4 2023 | 9 | $1.7M |
| Q3 2023 | 11 | $1.6M |